BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01297452
Recruitment Status : Completed
First Posted : February 16, 2011
Last Update Posted : March 31, 2017
Novartis Pharmaceuticals
Sai Life Sciences
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center